Back to calendar
Taysha Gene Therapies, Inc. (TSHA) Earnings
TSHA reports earnings on Tuesday, August 11, 2026
earnings report
August 11, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.11
Actual EPS: $-0.12
EPS surprise: -24.14%
Company overview
Market Cap$2.0B
PriceUSD 6.32
EPS (TTM)-0.40
52-week high7.30
52-week low2.69
SectorHealth Technology
IndustryBiotechnology
Employees99